| OLP | PRESS-RELEASE | neutral | 3/10 | One Liberty Properties, Inc. announced it has increased or maintained its dividend for over 33 consecutive years, signal | Jun 9, 2026 |
| ZS | PRESS-RELEASE | neutral | 4/10 | Zscaler announced the expansion of Project AI-Guardian to include technology alliance partners such as AWS, Google Cloud | Jun 9, 2026 |
| FLYW | PRESS-RELEASE | neutral | 4/10 | Flywire announced a partnership with Scholarship America, the largest nonprofit scholarship administrator, to digitize s | Jun 9, 2026 |
| SLE | PRESS-RELEASE | neutral | 4/10 | Super League announced a U.S. advertising sales partnership with Play.Works, the largest CTV games and video distributor | Jun 9, 2026 |
| BOSC | PRESS-RELEASE | neutral | 1/10 | B.O.S. Better Online Solutions Ltd. announced it will report its Q2 2026 results on August 20, 2026. | Jun 9, 2026 |
| OPTX | PRESS-RELEASE | bullish | 5/10 | Syntec Optics announced a $4.6 million purchase order for manufacturing laser blood-test cartridges and optical reader s | Jun 9, 2026 |
| SAIC | PRESS-RELEASE | bullish | 5/10 | SAIC won a leading position on a U.S. Air Force ABMS Digital Infrastructure contract valued at $192 million. The award i | Jun 9, 2026 |
| ELMT | PRESS-RELEASE | bullish | 4/10 | The Elmet Group announced a $4.3M government contract award to its subsidiary Elmet Technologies for developing domestic | Jun 9, 2026 |
| CYCU | PRESS-RELEASE | mixed | 6/10 | Cycurion closed its acquisition of Secuvant, LLC for total consideration of approximately $2.875M ($875k cash + 888,888 | Jun 9, 2026 |
| IRON | PRESS-RELEASE | bullish | 6/10 | Disc Medicine announced alignment with the FDA that the ongoing Phase 3 APOLLO study, if successful, can serve as the ba | Jun 9, 2026 |
| QXL | PRESS-RELEASE | neutral | 4/10 | Quantum X Labs announced a strategic cooperation agreement with IQCC (a Quantum Machines company) to evaluate its AI-bas | Jun 9, 2026 |
| MTSI | PRESS-RELEASE | neutral | 2/10 | MACOM announced a joint demonstration with Elve at IMS 2026 showcasing combined APD linearization with TWTA technology f | Jun 9, 2026 |
| WOR | PRESS-RELEASE | neutral | 1/10 | Worthington Enterprises, Inc. announced it will host a conference call on June 24 to discuss its fiscal Q4 2026 results. | Jun 9, 2026 |
| LMND | PRESS-RELEASE | neutral | 2/10 | Lemonade announced the availability of its renters insurance in North Dakota, marking a routine state-level expansion. T | Jun 9, 2026 |
| ZSPC | PRESS-RELEASE | neutral | 3/10 | zSpace announced a research collaboration where L'ABCD Edutainment used its AR/VR platform for 3D thyroid reconstruction | Jun 9, 2026 |
| ASO | PRESS-RELEASE | bullish | 7/10 | Academy Sports reported Q1 2026 EPS of $0.80 GAAP ($0.93 adjusted), well above the $0.92 consensus, on revenue of $1.442 | Jun 9, 2026 |
| VEON | PRESS-RELEASE | neutral | 2/10 | VEON appointed Serkan Ozturk as Chief of Staff & Strategy Officer, effective immediately. This is a routine leadership a | Jun 9, 2026 |
| ACTU | PRESS-RELEASE | bullish | 7/10 | Actuate Therapeutics announced that its lead drug elraglusib will be evaluated in the BEACON2 platform trial for relapse | Jun 9, 2026 |
| AMAT | PRESS-RELEASE | neutral | 2/10 | Applied Materials announced a quarterly cash dividend of $0.53 per share, payable Sept. 10, 2026, consistent with a 15% | Jun 9, 2026 |
| CVRX | PRESS-RELEASE | neutral | 5/10 | CVRx reported Q1 2026 EPS of -$0.50, beating consensus of -$0.52 by 4.5%, with revenue of $15.6M in line with estimates. | Jun 9, 2026 |
| ATHE | PRESS-RELEASE | bullish | 7/10 | Alterity Therapeutics announced a successful End-of-Phase 2 meeting with the FDA, achieving alignment on the pivotal Pha | Jun 9, 2026 |
| ACON | PRESS-RELEASE | neutral | 3/10 | Aclarion announced a Market Access Program with PRIA Healthcare to pursue U.S. payer coverage and reimbursement for its | Jun 9, 2026 |
| SAIL | PRESS-RELEASE | bullish | 6/10 | SailPoint reported Q1 2026 EPS of $0.08, beating consensus of $0.04 by 80.7%, on revenue of $276.1M (consensus $276.1M, | Jun 9, 2026 |
| IVVD | PRESS-RELEASE | neutral | 4/10 | Invivyd dosed first participants in the LIBERTY Phase 3 trial evaluating VYD2311 (mAb) vs. mRNA COVID-19 vaccine, with t | Jun 9, 2026 |
| BNR | PRESS-RELEASE | bearish | 6/10 | Burning Rock Biotech reported Q1 2026 revenue of RMB107.9M ($15.6M), down 18.9% YoY, with net loss widening to RMB17.5M | Jun 9, 2026 |
| NATH | PRESS-RELEASE | bearish | 6/10 | Nathan's Famous reported fiscal 2026 annual revenue growth of 9.4% to $162.1M, but net income fell 16.7% to $20.0M and d | Jun 9, 2026 |
| PSN | PRESS-RELEASE | bullish | 5/10 | Parsons announced a $73M contract award under the Air Force Research Laboratory's GARDEM mission, its fourth such award | Jun 9, 2026 |
| THCH | PRESS-RELEASE | bearish | 7/10 | TH International (Tims China) reported Q1 2026 revenue of RMB256.7M ($37.2M), a 14.6% YoY decline, with net loss widenin | Jun 9, 2026 |
| KBR | PRESS-RELEASE | neutral | 4/10 | KBR announced a $95 million cost-plus-fixed-fee contract from the U.S. Space Force's Air Force Research Laboratory to pr | Jun 9, 2026 |
| OCS | PRESS-RELEASE | neutral | 5/10 | Oculis announced the first patient randomized in PREDICT-1, a genotype-based registrational trial for Licaminlimab in dr | Jun 9, 2026 |